ARMOUR Residential REIT, Inc.
ARR
$14.86
+0.34%
ARMOUR Residential REIT, Inc. is a mortgage real estate investment trust that invests in fixed-rate, adjustable-rate, and hybrid adjustable-rate residential mortgage-backed securities issued or guaranteed by U.S. government-sponsored enterprises or Ginnie Mae, alongside U.S. Treasury securities and money market instruments. Operating as a highly leveraged, externally managed agency MBS carry vehicle with only 20 employees, ARMOUR is a niche income play whose returns hinge on the spread between its borrowing costs and the yield on its MBS portfolio rather than on operational differentiation. The current investor narrative is dominated by the tension between a headline dividend yield of roughly 17% and a first-quarter 2026 net loss of $54.9 million, which has raised fresh questions about whether the payout is covered by distributable earnings. Management's steady monthly dividend declarations and a 12.7% year-to-date share price decline have made ARR a battleground between income investors attracted by the yield and analysts wary of book-value erosion in a volatile rate environment.…
ARR
ARMOUR Residential REIT, Inc.
$14.86
Related headlines
Investment Opinion: Should I buy ARR Today?
The synthesized recommendation is Hold. ARR's 0.735x price-to-book discount and 17.06% dividend yield offer compelling value for income-focused investors, but the Q1 2026 net loss of $54.85 million and 7.94x leverage introduce substantial risk. Analyst targets average $18.375, implying 16.3% upside, but with only four analysts and no formal consensus rating, this signal is not strong enough to justify a Buy rating on its own.
Supporting evidence for a Hold includes the deep discount to book value (0.735x vs. sector 0.8x-1.1x), the high dividend yield (17.06%) with an 87.8% payout ratio, and trailing profitability (EPS $0.19, ROE 14.27%). However, the revenue collapse of 84.8% year-over-year and the negative quarterly EPS of -$0.49 underscore the volatility of the agency MBS carry trade. Free cash flow of $134.28 million on a trailing basis is positive, but the quarterly pattern is erratic, and the current ratio of 0.0083 highlights a fragile liquidity position. The implied upside to the average analyst target is 16.3%, but this is offset by the risk of further book value erosion.
The biggest risks that could invalidate the thesis are a dividend cut, a spike in repo funding costs, and a breakdown below the 52-week low of $13.98. The rating would upgrade to Buy if ARR demonstrates two consecutive quarters of distributable earnings covering the dividend and price-to-book recovers above 0.8x. It would downgrade to Sell if the dividend is cut or if price-to-book falls below 0.65x. Relative to its own history and peers, ARR appears undervalued on a price-to-book basis, but the discount is justified by elevated leverage and earnings uncertainty. The stock is fairly valued to slightly undervalued, but not a screaming buy given the risks.
Sign up to view all
ARR 12-Month Price Forecast
The forward-looking view is neutral with medium confidence. ARR's deep discount to book value and high dividend yield provide a margin of safety, but the Q1 2026 loss and extreme leverage create significant downside risk. The base case (55% probability) assumes stable rates and a maintained dividend, leading to a target range of $16.50-$18.00. The bull case (25%) hinges on a dovish Fed pivot and book value stabilization, while the bear case (20%) reflects a dividend cut or funding crisis. I would upgrade to bullish if ARR demonstrates two consecutive quarters of dividend coverage and price-to-book recovers above 0.80x. I would downgrade to bearish if the dividend is cut or if price-to-book falls below 0.65x.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on ARMOUR Residential REIT, Inc.'s 12-month outlook, with a consensus price target around $18.38 and implied upside of +23.6% versus the current price.
Average Target
$18.38
0 analysts
Implied Upside
+23.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$18 - $19
Analyst target range
Coverage of ARR is thin, with only 4 analysts contributing to the consensus, and the recommendation field is listed as "none," meaning there is no formal consensus rating to report. The average target price of $18.375 implies upside of approximately 16.3% from the current price of $15.80, which would represent a meaningful recovery if achieved. The target range is unusually tight, spanning from a low of $18.00 to a high of $19.00, a spread of just $1.00 or 5.4% of the average target, which signals strong conviction among the covering analysts about the direction and magnitude of the expected move. The consensus leans bullish on a price basis, but the absence of a formal recommendation and the small analyst count mean this signal should be weighted cautiously. The high target of $19.00 implies roughly 20.3% upside and would require either a re-rating of the price-to-book multiple back toward 0.88x or a recovery in net interest spreads that restores distributable earnings coverage of the dividend. The low target of $18.00 still implies 13.9% upside, suggesting that even the most conservative analyst expects the stock to recover from current levels, likely on the basis of the deep discount to book value and the high dividend yield. Institutional ratings show a mixed but slightly constructive pattern: Jones Trading upgraded ARR from Hold to Buy in January 2026 and has maintained a Buy rating through April 2026, while UBS has stayed Neutral since September 2025 and Janney Montgomery Scott upgraded to Buy in April 2025. The lack of recent downgrades and the presence of two Buy ratings suggest that analysts see the selloff as overdone relative to book value, but the tight target range and small coverage universe mean the stock is susceptible to sharp moves if a single analyst changes their view. With a short ratio of 0.0, there is no meaningful short-selling pressure to amplify a squeeze, but the low float of institutional interest also means liquidity can dry up quickly in a risk-off environment.
Bulls vs Bears: ARR Investment Factors
The bear case currently has stronger evidence due to the Q1 2026 net loss of $54.85 million, the 84.8% revenue decline, and the dangerously low current ratio of 0.0083. However, the bull case rests on the deep 0.735x price-to-book discount and a 17.06% dividend yield that, while at risk, remains a powerful draw for income investors. The single most important tension is whether the dividend is sustainable: if ARR can cover its payout from distributable earnings without further equity dilution, the stock could re-rate toward book value; if not, another dividend cut could trigger a sharp selloff. Analyst targets of $18.00-$19.00 imply 14-20% upside, but with only four analysts and no formal consensus rating, this signal is weak. Ultimately, the resolution of the dividend coverage question will determine whether ARR is a value trap or a high-yield opportunity.
Bullish
- Deep discount to book value: ARR trades at a price-to-book ratio of 0.735x, meaning the market values its agency MBS portfolio at roughly 73.5 cents on the dollar. This is below the sector's typical 0.8x-1.1x range and near the low end of ARR's own historical band (0.636x-0.878x), suggesting the selloff may be overdone if book value stabilizes.
- Analyst targets imply 16% upside: The average analyst target price is $18.375, representing 16.3% upside from the current $15.80. Even the lowest target of $18.00 implies 13.9% upside, and the tight $1.00 range (5.4% of the average) signals strong conviction among the four covering analysts.
- Massive dividend yield with recent coverage: The dividend yield of 17.06% is exceptionally high, and the payout ratio of 87.8% suggests the distribution is currently covered by trailing earnings. Management's consistent monthly dividend declarations provide a steady income stream that is attractive in a yield-starved market.
- Trailing profitability remains positive: Despite the Q1 2026 loss, trailing EPS is $0.19 and net margin is 24.7%, with ROE of 14.27% and ROA of 2.21%. These figures indicate that the core spread business can generate positive returns over a full cycle, even if quarterly results are volatile.
Bearish
- Q1 2026 net loss and margin collapse: ARR reported a net loss of $54.85 million in Q1 2026, a negative net margin of -98.0%, and a quarterly EPS of -$0.49. This is a stark reversal from the $211.70 million profit in Q4 2025 and raises serious questions about the sustainability of the dividend.
- Extreme leverage and liquidity risk: The debt-to-equity ratio is 7.94x, and the current ratio is a dangerously low 0.0083, meaning the company holds almost no liquid assets relative to liabilities. This heavy reliance on rolling repo financing makes ARR highly vulnerable to funding market disruptions.
- Revenue and earnings volatility: Revenue collapsed 84.8% year-over-year in Q1 2026 to $55.96 million, following a pattern of erratic swings: $194.54 million in Q2 2025, $393.49 million in Q3 2025, $349.01 million in Q4 2025. This volatility is driven by mark-to-market losses on the MBS portfolio and makes forecasting nearly impossible.
- Dividend may be partially funded by equity issuance: In Q1 2026, ARR issued $221.71 million of common stock while paying $89.44 million in dividends. This suggests the company is diluting existing shareholders to sustain the payout, a practice that erodes book value per share over time.
ARR Technical Analysis
ARR is in a mild but persistent downtrend, with the current price of $15.80 sitting just 31.1% above its 52-week low of $13.98 and 18.2% below its 52-week high of $19.31, placing it in the lower third of its annual range. The 1-year price change of +3.67% masks a deteriorating path, as the stock has given back most of its gains and now trades below where it began the year, with a year-to-date decline of 12.66%. This positioning near the lower end of the range signals that buyers have consistently faded rallies, and the burden of proof now rests on the bulls to defend the $14-16 zone rather than on momentum chasing. Short-term momentum has turned decisively negative, with a 1-month decline of 5.05% and a 3-month decline of 7.60% both steeper than the 6-month decline of 7.49%, indicating that selling pressure has accelerated rather than stabilized. The 1-month move also badly lags the S&P 500's -1.06% over the same period, producing a relative strength of -3.99%, while the 1-year relative strength of -12.55% and year-to-date relative strength of -24.74% confirm that ARR is being abandoned in favor of the broader market. With no RSI data provided, the persistent lower highs since the July 2026 peak near $17.30 suggest the stock is not yet oversold enough to attract contrarian flows. Key technical levels are clearly defined: support rests at the 52-week low of $13.98, roughly 11.5% below the current price, while resistance sits at the 52-week high of $19.31, about 22.2% above. A breakdown below $13.98 would mark a fresh 52-week low and likely trigger further momentum-driven selling, whereas a breakout above $19.31 would require a fundamental catalyst such as a dovish rate pivot or a decisive improvement in book value. The beta of 1.341 means ARR is roughly 34% more volatile than the S&P 500, and with a maximum drawdown of -19.04% over the period, position sizing should account for the fact that this is a high-beta, rate-sensitive instrument where a 1% market move can translate into a 1.34% move in ARR.
Beta
1.34
1.34x market volatility
Max Drawdown
-22.5%
Largest decline past year
52-Week Range
$14-$19
Price range past year
Annual Return
-0.5%
Cumulative gain past year
| Period | ARR Return | S&P 500 |
|---|---|---|
| 1m | -9.3% | -0.6% |
| 3m | -11.3% | +2.1% |
| 6m | -4.0% | +17.6% |
| 1y | -0.5% | +15.7% |
| ytd | -17.9% | +11.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ARR Fundamental Analysis
The revenue trajectory is deeply unstable, with first-quarter 2026 revenue of $55.96 million representing a year-over-year decline of 84.8% from the $368.23 million reported in Q1 2025, a collapse driven by the mark-to-market swings inherent in the MBS portfolio rather than by a loss of core earning assets. The multi-quarter pattern is erratic: revenue swung from $194.54 million in Q2 2025 to $393.49 million in Q3 2025, then to $349.01 million in Q4 2025 before collapsing to $55.96 million in Q1 2026, illustrating that reported revenue for this agency MBS carry trade is dominated by unrealized gains and losses rather than recurring spread income. The more stable signal is the interest income line, which has grown from $172.88 million in Q1 2025 to $236.48 million in Q4 2025, though it fell to zero in Q1 2026 as the company reclassified its presentation, making trend analysis difficult. For investors, the key takeaway is that headline revenue is not a reliable growth indicator for ARR; the investment case rests on net interest spread and book value per share, neither of which is trending favorably. Profitability has deteriorated sharply, with Q1 2026 producing a net loss of $54.85 million and a negative net margin of -98.0%, a dramatic reversal from the $211.70 million profit and 60.7% net margin in Q4 2025. The gross margin of 78.2% in Q1 2026 remains high in absolute terms but is down from 97.1% in Q4 2025 and 97.5% in Q3 2025, reflecting compression in the spread between asset yields and financing costs. On a trailing basis the company still shows a positive EPS of $0.19 and a net margin of 24.7%, but the quarterly loss and the -0.49 quarterly EPS underscore that the trailing figures are backward-looking and mask a rapid deterioration. For a mortgage REIT, a 97% gross margin is typical of the agency MBS model, so the drop to 78% is a meaningful warning sign that hedging costs and repo funding expenses are eating into returns. The balance sheet is highly leveraged and cash-poor, with a debt-to-equity ratio of 7.94x and a current ratio of just 0.0083, meaning the company holds almost no liquid current assets relative to liabilities and depends entirely on rolling repo financing. Free cash flow on a trailing basis is $134.28 million, but the quarterly pattern is volatile, ranging from $111.56 million in Q1 2026 to -$37.81 million in Q3 2025, and the dividend payout ratio of 87.8% leaves little margin for error if earnings decline further. The ROE of 14.27% and ROA of 2.21% look respectable on a trailing basis, but with a debt-to-equity ratio near 8x, that ROE is a product of leverage rather than operational excellence, and the cash flow to debt ratio of 0.006 highlights how thin the cash buffer is relative to the debt load. The company funded itself with $221.71 million of common stock issuance in Q1 2026 while paying out $89.44 million in dividends, a pattern that suggests it is partially funding distributions through equity issuance, which is dilutive to existing holders.
Quarterly Revenue
$55958000.0B
2026-03
Revenue YoY Growth
-84.8%
YoY Comparison
Gross Margin
78.2%
Latest Quarter
Free Cash Flow
$134276000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ARR Overvalued?
Because ARMOUR reported positive trailing net income of $0.19 per share, the PE ratio is the appropriate primary metric, and the trailing PE of 5.34x is extremely low in absolute terms. However, the forward PE of 5.39x is essentially identical to the trailing figure, which implies the market is pricing in no earnings growth at all, a stark contrast to the analyst consensus EPS estimate of $2.89 for the coming year that would imply a forward PE closer to 5.5x on that higher number. The gap between the trailing EPS of $0.19 and the estimated EPS of $2.89 is enormous and reflects the extreme volatility of mortgage REIT earnings, making the PE ratio a noisy and unreliable valuation anchor for this name. On a price-to-book basis, ARR trades at 0.735x, a discount to book value that is the more meaningful valuation signal for a mortgage REIT, as it indicates the market values the portfolio at roughly 73.5 cents on the dollar. Compared with the mortgage REIT sector, where price-to-book ratios typically range from 0.8x to 1.1x for agency-focused peers, ARR's 0.735x represents a discount of roughly 8% to 25% depending on the peer set, a discount that is partially justified by the Q1 2026 loss and the 7.94x leverage. The price-to-sales ratio of 1.27x and EV-to-sales of 41.0x are distorted by the revenue collapse and the massive repo book, while the EV-to-EBITDA of 20.2x is elevated for a spread business and suggests the market is not pricing in a recovery in net interest margin. The dividend yield of 17.06% is the standout metric, but with a payout ratio of 87.8% and a quarterly loss, the market is clearly discounting the sustainability of that distribution, which explains why the stock trades below book. Historically, ARR's price-to-book ratio has ranged from a low of 0.636x in Q3 2022 to a high of 0.878x in Q4 2025, and the current 0.735x sits in the lower half of that band, closer to the 2022 trough than the 2025 peak. The historical PE ratio has been wildly unstable, swinging from -8.51x in Q1 2026 to 13.36x in Q1 2025 and 2.38x in Q4 2025, which confirms that PE is not a useful historical anchor for this business. The current price-to-book of 0.735x is below the 0.878x seen just two quarters ago, implying that the market has repriced the portfolio downward by roughly 16% on a book-value basis, a move that reflects both realized losses and the market's skepticism about future spreads.
PE
5.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 2x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are severe. The debt-to-equity ratio of 7.94x and current ratio of 0.0083 mean ARR operates with virtually no liquidity buffer, relying entirely on rolling repo financing to fund its MBS portfolio. The Q1 2026 net loss of $54.85 million and negative net margin of -98.0% highlight how quickly spread compression can erode earnings, and the 87.8% payout ratio leaves little room for error. Furthermore, the company issued $221.71 million in common stock in Q1 2026 while paying $89.44 million in dividends, indicating that the payout may be partially funded by dilution, which threatens book value per share. With only 20 employees and an externally managed structure, operational risk is concentrated in management's ability to navigate rate cycles and hedging costs.
Market and competitive risks are equally daunting. ARR's beta of 1.341 means it is 34% more volatile than the S&P 500, so a 1% market decline could translate into a 1.34% drop in ARR. The stock has underperformed the S&P 500 by 24.74% year-to-date and 12.55% over the past year, reflecting a broader rotation away from rate-sensitive mortgage REITs. Valuation compression is a real threat: if the price-to-book multiple falls from 0.735x toward the 2022 low of 0.636x, that would imply a further 13.5% downside. Additionally, the tight analyst target range ($18.00-$19.00) and thin coverage (4 analysts) mean a single downgrade could trigger outsized selling pressure. Recent news of steady dividend declarations offers no growth catalyst, and the lack of formal consensus rating adds uncertainty.
In a worst-case scenario, a combination of rising interest rates, widening mortgage spreads, and a dividend cut could drive ARR to its 52-week low of $13.98, representing an 11.5% decline from the current price of $15.80. If funding markets seize up and the company is forced to sell assets at a loss, the stock could fall further, potentially testing the 2022 low price-to-book multiple of 0.636x, which would imply a price near $13.50 (assuming book value remains constant). The maximum drawdown over the past period was -19.04%, and with a beta of 1.341, a market correction could easily push ARR down 20-25% from current levels. Investors could lose 11.5% to 25% in a severe adverse scenario, with the dividend also at risk of being cut, compounding total return losses.
FAQ
The most severe risk is financial: ARR's debt-to-equity ratio of 7.94x and current ratio of 0.0083 mean it relies entirely on rolling repo financing, making it vulnerable to funding market disruptions. Second, dividend risk is high, as the 87.8% payout ratio and Q1 2026 net loss of $54.85 million suggest the payout may be unsustainable, and the company issued $221.71 million in stock while paying $89.44 million in dividends, indicating potential dilution. Third, market risk is elevated with a beta of 1.341, meaning ARR is 34% more volatile than the S&P 500, and it has underperformed the index by 24.74% year-to-date. Fourth, competitive and regulatory risks include changes in government MBS issuance or Fed policy that could compress spreads. These risks are ranked from most to least severe, with financial and dividend risks being the most immediate.
Our 12-month forecast presents three scenarios. The base case (55% probability) targets $16.50-$18.00, assuming stable interest rates and a maintained dividend. The bull case (25% probability) targets $18.00-$19.00, driven by a dovish Fed pivot and book value stabilization. The bear case (20% probability) targets $13.98-$15.00, reflecting a dividend cut or funding crisis. The most likely scenario is the base case, which assumes no major change in the interest rate environment and that ARR continues to cover its dividend from distributable earnings. However, given the Q1 2026 loss, the risk of a bear case outcome is not negligible, and investors should monitor dividend coverage closely.
ARR appears undervalued on a price-to-book basis, trading at 0.735x compared to the mortgage REIT sector average of 0.8x-1.1x. This discount is partially justified by the company's high leverage and recent quarterly loss, but it also suggests the market is pricing in a pessimistic scenario. The trailing PE of 5.34x and forward PE of 5.39x are extremely low, but these metrics are distorted by the volatility of mortgage REIT earnings. The dividend yield of 17.06% is well above market averages, but the 87.8% payout ratio and Q1 2026 loss raise questions about sustainability. Overall, the stock is undervalued relative to book value, but the discount reflects real risks, so it is not a clear-cut bargain.
ARR is a mixed proposition. On the positive side, it trades at a 0.735x price-to-book discount and offers a 17.06% dividend yield, with analyst targets implying 16.3% upside to $18.375. However, the company reported a $54.85 million net loss in Q1 2026, has a debt-to-equity ratio of 7.94x, and a current ratio of just 0.0083, indicating significant financial risk. The dividend payout ratio of 87.8% leaves little margin for error, and the stock has underperformed the S&P 500 by 24.74% year-to-date. For income investors who can tolerate volatility and potential dividend cuts, it may be a speculative buy, but for most investors, the risk/reward is not compelling enough to justify a strong buy recommendation.
ARR is more suitable for short-term trading or as a tactical income position rather than a long-term core holding. Its high beta of 1.341 and maximum drawdown of -19.04% indicate significant volatility, and the 17.06% dividend yield, while attractive, is at risk of being cut. The company's external management structure and 7.94x leverage make it sensitive to interest rate cycles, and its book value has eroded over time. For long-term investors, the total return may be compromised by dividend cuts and dilution. A suggested holding period is 6-12 months, with active monitoring of dividend coverage and interest rate trends. Short-term traders might capitalize on volatility around earnings or Fed announcements, but should use tight stop-losses given the downside risk to $13.98.